ZHX2 and hepatocellular carcinoma: To explore the role of ZHX2 in the I-125-induced anticancer effects on HCC, ZHX2 was overexpressed or knocked down in HepG2 and SMMC7721 cells, as mentioned above, and the cells were then treated with I-125.